Innovation

Compositions and Methods for Tympanic Membrane Transmigration

University of California System: University of California, San Diego Technology Transfer Office
posted on 01/19/2012

Otitis media is one of the most common diseases of childhood, resulting in more physician visits and surgeries than any other pediatric disorder. Persistent or recurrent otitis media can damage the middle or inner ear and cause permanent hearing loss. There exists a need to identify targets for potential new therapies in this disease.


Innovation Details
 

Detailed Description

Medical researchers at UC San Diego have established that it is possible to translocate particles across the tympanic membrane and have the potential for drug delivery to the inner ear. Historically the eardrum was viewed as impermeable to particles. This invention identifies specific compositions capable of transmigrating particles across the eardrum, as well a description of the process to identify compositions capable of translocating particles across biological membranes.

This technology has potential for treating numerous ear disorders (e.g. acute otitis media, recurrent ototos media, chronic otitis media, purlulent otitis media, otitis media with effusion, cholesteatoma, tympanosclerosis, otosclerosis, tinnitus, vertigo, Meniere’s disease, and various forms of sensorineural hearing loss).

File Number: 22225 


IP Protection

Copyright: ©2012, The Regents of the University of California

License Online

This innovation currently is not available for online licensing. Please contact University of California, San Diego Technology Transfer Office at University of California System: University of California, San Diego Technology Transfer Office for more information.

Request more info via email request more info
People

Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

8,815 members 16,688 innovations 159 organizations

Browse

Scott Steele, coordinator of the CTSA-IP initiative and director of research alliances at the University of Rochester

"With more than 3,700 innovations from CTSA member institutions already on the iBridge Network, we're garnering worldwide exposure for the breakthroughs our researchers are accomplishing while moving toward our goal of increasing human health through clinical and translational research."  read more...